» Articles » PMID: 24963741

Cut-off Values of Serum IgE (total and A. fumigatus -specific) and Eosinophil Count in Differentiating Allergic Bronchopulmonary Aspergillosis from Asthma

Overview
Journal Mycoses
Specialty Microbiology
Date 2014 Jun 26
PMID 24963741
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The cut-off values of immunological tests employed in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) have never been validated. Herein, we compare the immunological findings in patients with ABPA and asthma using receiver operating characteristic analysis. Consecutive asthmatic subjects underwent all the following investigations: Aspergillus skin test, IgE levels (total and A. fumigatus-specific), Aspergillus precipitins, eosinophil count, chest radiograph and CT chest. There were 372 subjects (179 men, mean age 35.9 years) with a mean asthma duration of 8 years. ABPA was diagnosed in 76 patients (64 bronchiectasis, 12 without bronchiectasis). ABPA was separated from asthma using the best cut-off values of total IgE, A. fumigatus IgE and total eosinophil count of 2347 IU ml(-1) , 1.91 kUA l(-1) and 507 cells per μl respectively. The sensitivity/specificity of these parameters were 87/81%; 99/87%; and, 79/76% respectively. The corresponding AUC values were 0.95, 0.90 and 0.82 respectively. The combination of these three tests at the aforementioned cut-offs provided 100% specificity. Our study provides evidence-based cut-off values of IgE (total and A. fumigatus-specific) and eosinophil counts in differentiating ABPA from asthma. As this is a single centre retrospective study, further studies from different centres are required, as these values could vary by ethnicity and environmental exposure.

Citing Articles

High level of initial Aspergillus fumigatus-specific IgE links increased risk of exacerbation in allergic bronchopulmonary aspergillosis patients.

Qian H, Xu J, Fan R, Shi J, Lu H, Ye L Respir Res. 2025; 26(1):95.

PMID: 40065361 PMC: 11895152. DOI: 10.1186/s12931-025-03171-3.


Detection of Specific IgE against Molds Involved in Allergic Bronchopulmonary Mycoses in Patients with Cystic Fibrosis.

Barrera C, Schwarz C, Delhaes L, Gal S, Ramel S, Gangneux J Mycopathologia. 2024; 189(4):68.

PMID: 39023843 DOI: 10.1007/s11046-024-00870-1.


Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

Agarwal R, Sehgal I, Muthu V, Denning D, Chakrabarti A, Soundappan K Eur Respir J. 2024; 63(4).

PMID: 38423624 PMC: 10991853. DOI: 10.1183/13993003.00061-2024.


Comparison of -specific antibody cut-offs for the diagnosis of aspergillosis.

Hsiao C, Yen T, Wu Y, Chen J, Chen Y, Huang W Front Microbiol. 2022; 13:1060727.

PMID: 36560943 PMC: 9763268. DOI: 10.3389/fmicb.2022.1060727.


Basophil Activation Test With Aspergillus Molecules: The Case for ABPA.

Michel M, Sereme Y, Mankouri F, Gouitaa M, Gautier C, Mege J Front Allergy. 2022; 3:898731.

PMID: 36238933 PMC: 9552950. DOI: 10.3389/falgy.2022.898731.